Skip to main content

Table 1 Patient demographic and baseline characteristics

From: Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

Characteristic

Values

Number enrolled

29

Sex: female/male

21/8 (74% female)

Age at baseline: mean ± SD years

33.9 ± 8.9

Ethnicity (self-reported): number (%)

 

 White (non-Hispanic)

14 (48.2%)

 Hispanic/Latino/Mexican

4 (13.8%)

 African American

6 (20.7%)

 Asian

4 (13.8%)

 Unknown

1 (3.45%)

Treatment naïve at baseline: number (%)

6 (20.7%)

Disease duration from diagnosis: mean ± SD years

3.1 ± 2.5

Disease duration from symptom onset: mean ± SD years

4.7 ± 3.8

Number of relapses 2 years prior to baseline: mean ± SD

2.5 ± 0.7

Baseline EDSS: mean ± SD

3.1 ± 1.1